by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract INTRODUCTION Cerebral amyloid angiopathy (CAA) is a leading cause of lobar intracerebral hemorrhage (ICH) in the elderly. The influence of apolipoprotein E (APOE) variants, CAA pathology, and concomitant Alzheimer’s disease (AD) neuropathologic changes...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract INTRODUCTION Dementia is a public health challenge and exposures likely contribute to risk, though many have not been evaluated. We screened chemicals for enrichment with dementia genes and related pathways. METHODS We obtained gene lists from Agora and the...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract INTRODUCTION Sleep is a modifiable risk factor in Alzheimer’s disease (AD), but its relationship to medial temporal lobe (MTL) subfields and responsiveness to lifestyle interventions remain unclear. METHODS In the Dementia-Multi-Objective Validation of...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Dementia, Ahead of Print. South Texas has among the highest dementia prevalence rates in the United States, yet communities in the region remain consistently underrepresented in dementia research. Aligning research studies with what matters to communities most...
by Clinical Neuropsychologist Online | Monday, August 24, 2026 | Dementia
Abstract INTRODUCTION Down syndrome (DS) is caused by a complete or partial trisomy of chromosome 21, resulting in variable intellectual disabilities and a high risk for early-onset Alzheimer’s disease (DS-AD). Dysregulation of the mammalian target of rapamycin...
